KO-Bagroven

KO-Bagroven


PRESCRIPTION

Download the instruction

The therapeutic effect and mechanism of action of the drug are based on the pharmacological properties of the active components included in its composition.

Manual

KO-Bagroven 10 +12.5 mg: each tablet contains:

  • Lisinopril USP eq. anhydrous lisinopril 10 mg;
  • Hydrochlorothiazide BP 12.5 mg.

KO-Bagroven 20 +12.5 mg: each tablet contains:

  • Lisinopril USP eq. anhydrous lisinopril 20 mg;
  • Hydrochlorothiazide BP 12.5 mg.

The drug is used to treat patients with arterial hypertension, including renovascular hypertension, who require combination antihypertensive therapy.

The drug is taken orally, it is recommended to swallow the tablet whole, without chewing or crushing, with the required amount of water. If necessary, the tablet can be divided. Duration of treatment and dose
The drug is determined by the attending physician individually for each patient.

Arterial hypertension:
1 tablet 10 mg + 12.5 mg 1 time per day. If necessary, the dose can be increased to 20 mg + 12.5 mg 1 time per day.

Doses for renal failure:
In patients with creatinine clearance more than 30 ml/min and less than 80 ml/min, the drug can be used only after titrating the dose of the individual components of the drug.

The recommended starting dose of lisinopril for uncomplicated renal failure is 5-10 mg.